New combo pill aims to slash dangerous blood fats in High-Risk patients
NCT ID NCT03540355
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study tested a drug called Cipros 20 in 406 adults with dyslipidemia (abnormal blood fats) and high heart disease risk. The goal was to see if it lowers triglycerides and LDL cholesterol more effectively than a placebo. Participants took the medication and had their blood fat levels measured over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allergisa
Campinas, São Paulo, Brazil
Conditions
Explore the condition pages connected to this study.